التفاصيل البيبلوغرافية
العنوان: |
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer |
المؤلفون: |
Timothy Tree, Bernard V. North, Sophie Papa, K. Owczarczyk, Sultan Abdul-Jawad, Hartmut Kristeleit, Kamila Sychowska, Piers E.M. Patten, Sheeba Irshad, Clara Domingo-Vila, Catherine Tremain, Jennifer Vidler, Paul Fields, Thomas Lechmere, Emily Pollock, Rosalind Graham, Carl Graham, Jeffrey Seow, Leticia Monin, Thanussuyah Alaguthurai, Miguel Muñoz-Ruiz, Michael H. Malim, Jack Cooper, Katie J. Doores, Charalampos Gousis, Adrian Hayday, Duncan R. McKenzie, Angela Swampillai |
المصدر: |
Cancer Cell |
بيانات النشر: |
Published by Elsevier Inc., 2021. |
سنة النشر: |
2021 |
مصطلحات موضوعية: |
Cancer Research, 2019-20 coronavirus outbreak, Cellular immunity, COVID-19 Vaccines, Time Factors, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), T-Lymphocytes, Antibodies, Viral, Article, Immunogenicity, Vaccine, Neoplasms, medicine, Humans, In patient, BNT162 Vaccine, Immunization Schedule, Messenger RNA, Immunity, Cellular, business.industry, SARS-CoV-2, Vaccination, Case-control study, Cancer, COVID-19, medicine.disease, Virology, Immunity, Humoral, Treatment Outcome, Oncology, Case-Control Studies, Immunoglobulin G, Host-Pathogen Interactions, Spike Glycoprotein, Coronavirus, Cytokines, business |
اللغة: |
English |
تدمد: |
1878-3686 1535-6108 |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92f3f08b823ccf3eed45ea9d826b9afd http://europepmc.org/articles/PMC8506107 |
حقوق: |
OPEN |
رقم الأكسشن: |
edsair.doi.dedup.....92f3f08b823ccf3eed45ea9d826b9afd |
قاعدة البيانات: |
OpenAIRE |